Published in Infect Immun on February 01, 1995
Tularemia. Clin Microbiol Rev (2002) 8.51
Francisella tularensis: taxonomy, genetics, and Immunopathogenesis of a potential agent of biowarfare. Annu Rev Microbiol (2006) 2.68
Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun (2001) 2.51
Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect Immun (2006) 2.12
Francisella tularensis live vaccine strain induces macrophage alternative activation as a survival mechanism. J Immunol (2008) 2.06
Toll-like receptor 2-mediated signaling requirements for Francisella tularensis live vaccine strain infection of murine macrophages. Infect Immun (2007) 1.98
Fine tuning inflammation at the front door: macrophage complement receptor 3-mediates phagocytosis and immune suppression for Francisella tularensis. PLoS Pathog (2013) 1.71
Microarray analysis of human monocytes infected with Francisella tularensis identifies new targets of host response subversion. PLoS One (2008) 1.67
Interleukin-12 in infectious diseases. Clin Microbiol Rev (1997) 1.63
Working toward the future: insights into Francisella tularensis pathogenesis and vaccine development. Microbiol Mol Biol Rev (2009) 1.59
Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion. Infect Immun (2007) 1.57
Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. Infect Immun (1999) 1.36
Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice. Infect Immun (2009) 1.19
Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia. Infect Immun (2007) 1.15
Glycogen synthase kinase-3beta (GSK3beta) inhibition suppresses the inflammatory response to Francisella infection and protects against tularemia in mice. Mol Immunol (2008) 1.11
Characterization of rationally attenuated Francisella tularensis vaccine strains that harbor deletions in the guaA and guaB genes. Vaccine (2009) 1.01
Coactivating signals for the hepatic lymphocyte gamma interferon response to Francisella tularensis. Infect Immun (2006) 1.00
Programmed cell death and the pathogenesis of tissue injury induced by type A Francisella tularensis. FEMS Microbiol Lett (2009) 0.97
A conserved and immunodominant lipoprotein of Francisella tularensis is proinflammatory but not essential for virulence. Microb Pathog (2008) 0.90
Influence of the bcg locus on natural resistance to primary infection with the facultative intracellular bacterium Francisella tularensis in mice. Infect Immun (2000) 0.89
Members of the Francisella tularensis phagosomal transporter subfamily of major facilitator superfamily transporters are critical for pathogenesis. Infect Immun (2012) 0.86
Live attenuated tularemia vaccines: recent developments and future goals. Vaccine (2013) 0.86
Significance analysis of xMap cytokine bead arrays. Proc Natl Acad Sci U S A (2012) 0.85
IKKβ in myeloid cells controls the host response to lethal and sublethal Francisella tularensis LVS infection. PLoS One (2013) 0.80
Cytokine response in Balb/c mice infected with Francisella tularensis LVS and the Pohang isolate. J Vet Sci (2008) 0.77
A human macrophage - hepatocyte co-culture model for comparative studies of infection and replication of Francisella tularensis LVS strain and subspecies holarctica and mediasiatica. BMC Microbiol (2016) 0.75
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. Science (1993) 19.80
Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991) 16.81
Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J Exp Med (1991) 7.52
IL-4 directs the development of Th2-like helper effectors. J Immunol (1990) 7.20
Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J Exp Med (1988) 7.02
Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A (1993) 6.87
Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A (1993) 6.33
Nature of protective immunity to Francisella tularensis. Rev Infect Dis (1989) 4.75
Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in scid mice. J Immunol (1989) 4.70
The adjuvant effect of interleukin-12 in a vaccine against Leishmania major. Science (1994) 4.38
Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli. Infect Immun (1991) 4.18
Live vaccine strain of Francisella tularensis: infection and immunity in mice. Infect Immun (1991) 3.99
Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun (1988) 3.70
Early gamma interferon production by natural killer cells is important in defense against murine listeriosis. Infect Immun (1991) 3.59
EVALUATION OF LIVE TULAREMIA VACCINE PREPARED IN A CHEMICALLY DEFINED MEDIUM. Appl Microbiol (1965) 3.48
Association between virulence of Yersinia pestis and suppression of gamma interferon and tumor necrosis factor alpha. Infect Immun (1993) 3.16
Activation of macrophages for destruction of Francisella tularensis: identification of cytokines, effector cells, and effector molecules. Infect Immun (1992) 3.09
In vivo modulation of the murine immune response to Francisella tularensis LVS by administration of anticytokine antibodies. Infect Immun (1992) 3.07
Role of cytokines in the differentiation of CD4+ T-cell subsets in vivo. Immunol Rev (1991) 2.85
Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect Immun (1994) 2.61
Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions. Infect Immun (1984) 2.37
The requirement for gamma interferon in resistance of mice to experimental tularemia. Microb Pathog (1989) 2.35
Interactions between endogenous gamma interferon and tumor necrosis factor in host resistance against primary and secondary Listeria monocytogenes infections. Infect Immun (1989) 2.28
Experimental murine tularemia caused by Francisella tularensis, live vaccine strain: a model of acquired cellular resistance. Microb Pathog (1987) 2.13
Emergence of NK1.1+ cells as effectors of IFN-gamma dependent immunity to Toxoplasma gondii in MHC class I-deficient mice. J Exp Med (1993) 2.07
In vitro interactions between rabbit alveolar macrophages and Pasteurella tularensis. J Bacteriol (1966) 2.06
Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol Immunol (1992) 1.82
Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J Clin Microbiol (1987) 1.64
Kinetic analysis of cytokine gene expression in the livers of naive and immune mice infected with Listeria monocytogenes. The immediate early phase in innate resistance and acquired immunity. J Immunol (1992) 1.63
T-cell-independent resistance to infection and generation of immunity to Francisella tularensis. Infect Immun (1993) 1.62
Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice. Infect Immun (1994) 1.49
Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun (1992) 1.46
The tularaemia vaccine. J Chem Technol Biotechnol (1994) 1.43
Analysis of the time course of IFN-gamma mRNA and protein production during primary murine listeriosis. The immune phase of bacterial elimination is not temporally linked to IFN production in vivo. J Immunol (1991) 1.40
Interleukin-12 but not interferon-gamma production correlates with induction of T helper type-1 phenotype in murine candidiasis. Eur J Immunol (1994) 1.33
Diversity of Francisella tularensis antigens recognized by human T lymphocytes. Infect Immun (1990) 1.28
Infection with Leishmania major induces interleukin-12 production in vivo. Immunol Lett (1994) 1.26
Early expression of cytokine mRNA in mice infected with Listeria monocytogenes. Infect Immun (1992) 1.23
Dynamics of lymphocytes and inflammatory cells recruited in liver during murine listeriosis. A cytofluorimetric study. J Immunol (1991) 1.21
Cytokine expression in vivo during murine listeriosis. Infection with live, virulent bacteria is required for monokine and lymphokine messenger RNA accumulation in the spleen. J Immunol (1992) 1.15
Various membrane proteins of Francisella tularensis induce interferon-gamma production in both CD4+ and CD8+ T cells of primed humans. Immunology (1992) 1.00
Assembly of vaccinia virus: the second wrapping cisterna is derived from the trans Golgi network. J Virol (1994) 4.67
Assembly of vaccinia virus: role of the intermediate compartment between the endoplasmic reticulum and the Golgi stacks. J Cell Biol (1993) 4.34
Analysis of 16S ribosomal DNA sequences of Francisella strains and utilization for determination of the phylogeny of the genus and for identification of strains by PCR. Int J Syst Bacteriol (1994) 3.37
Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J Cell Biol (1994) 2.92
Francisella tularensis induces cytopathogenicity and apoptosis in murine macrophages via a mechanism that requires intracellular bacterial multiplication. Infect Immun (2001) 2.51
Evaluation of PCR-based methods for discrimination of Francisella species and subspecies and development of a specific PCR that distinguishes the two major subspecies of Francisella tularensis. J Clin Microbiol (2000) 2.40
Identification of proteins of Francisella tularensis induced during growth in macrophages and cloning of the gene encoding a prominently induced 23-kilodalton protein. Infect Immun (1997) 2.40
Antigen from Francisella tularensis: nonidentity between determinants participating in cell-mediated and humoral reactions. Infect Immun (1984) 2.37
A capsule-deficient mutant of Francisella tularensis LVS exhibits enhanced sensitivity to killing by serum but diminished sensitivity to killing by polymorphonuclear leukocytes. Infect Immun (1988) 2.34
Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia. J Clin Microbiol (2000) 2.31
Characterization of two unusual clinically significant Francisella strains. J Clin Microbiol (1996) 2.20
Assembly of vaccinia virus: effects of rifampin on the intracellular distribution of viral protein p65. J Virol (1994) 2.17
Eps15 is a component of clathrin-coated pits and vesicles and is located at the rim of coated pits. J Biol Chem (1996) 2.16
Localization of the Lys, Asp, Glu, Leu tetrapeptide receptor to the Golgi complex and the intermediate compartment in mammalian cells. J Cell Biol (1994) 2.04
Extensive allelic variation among Francisella tularensis strains in a short-sequence tandem repeat region. J Clin Microbiol (2001) 2.03
Identification of Francisella species and discrimination of type A and type B strains of F. tularensis by 16S rRNA analysis. Appl Environ Microbiol (1990) 2.03
Detection of Francisella tularensis in ulcers of patients with tularemia by PCR. J Clin Microbiol (1997) 1.99
A case of chronic progressive rhinocerebral mucormycosis treated with liposomal amphotericin B and surgery. Clin Infect Dis (1993) 1.94
Identification and localization of polycystin, the PKD1 gene product. J Clin Invest (1996) 1.84
Immunogenicity and toxicity of lipopolysaccharide from Francisella tularensis LVS. FEMS Microbiol Immunol (1992) 1.82
Inability of the Francisella tularensis lipopolysaccharide to mimic or to antagonize the induction of cell activation by endotoxins. Infect Immun (1996) 1.75
Degradation of human immunoglobulins G and M and complement factors C3 and C5 by black-pigmented Bacteroides. J Med Microbiol (1985) 1.73
Characterization of a novel 63 kDa membrane protein. Implications for the organization of the ER-to-Golgi pathway. J Cell Sci (1993) 1.66
Immunospecific T-lymphocyte stimulation by membrane proteins from Francisella tularensis. J Clin Microbiol (1987) 1.64
Characterization and classification of strains of Francisella tularensis isolated in the central Asian focus of the Soviet Union and in Japan. J Clin Microbiol (1992) 1.63
Elevated plasma levels of tumor necrosis factor (TNF)-alpha, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J Infect Dis (1996) 1.54
A wild and an attenuated strain of Francisella tularensis differ in susceptibility to hypochlorous acid: a possible explanation of their different handling by polymorphonuclear leukocytes. Infect Immun (1984) 1.53
Phagocytosis and killing of Francisella tularensis by human polymorphonuclear leukocytes. Infect Immun (1983) 1.52
CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect Immun (1994) 1.50
Nucleotide sequence and T cell epitopes of a membrane protein of Francisella tularensis. J Immunol (1990) 1.50
Assembly of vaccinia virus: incorporation of p14 and p32 into the membrane of the intracellular mature virus. J Virol (1995) 1.47
Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium. Infect Immun (1992) 1.46
Epidemiological analysis of tularemia in Sweden 1931-1993. FEMS Immunol Med Microbiol (1996) 1.46
Superoxide dismutase isozymes in different human tissues, their genetic control and intracellular localization. Hum Hered (1973) 1.45
The 17 kDa lipoprotein and encoding gene of Francisella tularensis LVS are conserved in strains of Francisella tularensis. Microb Pathog (1992) 1.42
Stimulation of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1975) 1.42
Cytocidal and apoptotic effects of the ClyA protein from Escherichia coli on primary and cultured monocytes and macrophages. Infect Immun (2000) 1.39
Preliminary analysis and annotation of the partial genome sequence of Francisella tularensis strain Schu 4. J Appl Microbiol (2001) 1.37
Rapid local expression of interleukin-12, tumor necrosis factor alpha, and gamma interferon after cutaneous Francisella tularensis infection in tularemia-immune mice. Infect Immun (1999) 1.36
Amplification and restriction endonuclease digestion of a large fragment of genes coding for rRNA as a rapid method for discrimination of closely related pathogenic bacteria. J Clin Microbiol (1996) 1.35
Isolation of lymphocytes from blood. A procedure combining nylon fibre filtration and differential centrifugation. Acta Pathol Microbiol Scand B Microbiol Immunol (1970) 1.32
Increased synthesis of DnaK, GroEL, and GroES homologs by Francisella tularensis LVS in response to heat and hydrogen peroxide. Infect Immun (1994) 1.32
Oligomerization of a trans-Golgi/trans-Golgi network retained protein occurs in the Golgi complex and may be part of its retention. J Biol Chem (1995) 1.30
Pharmacotherapy for obesity: a quantitative analysis of four decades of published randomized clinical trials. Int J Obes Relat Metab Disord (2002) 1.29
Use of RNA hybridization in the diagnosis of a case of ulceroglandular tularemia. Eur J Clin Microbiol Infect Dis (1990) 1.26
Sequencing of the Francisella tularensis strain Schu 4 genome reveals the shikimate and purine metabolic pathways, targets for the construction of a rationally attenuated auxotrophic vaccine. Microb Comp Genomics (2000) 1.25
Coagulase-negative staphylococci: update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur J Clin Microbiol Infect Dis (2011) 1.22
Autolysis of Neisseria gonorrhoeae. Relation between mechanical stability and viability. Br J Vener Dis (1976) 1.22
The T-cell-stimulating 17-kilodalton protein of Francisella tularensis LVS is a lipoprotein. Infect Immun (1991) 1.22
Autism associated with marker chromosome. J Am Acad Child Adolesc Psychiatry (1991) 1.22
Inhibition of PHA-induced lymphocyte stimulation by the pregnancy zone protein. FEBS Lett (1973) 1.21
Pulmonary involvement in nephropathia epidemica as demonstrated by computed tomography. Infection (1992) 1.21
Automatic analysis of the EMG interference pattern. Electroencephalogr Clin Neurophysiol (1983) 1.19
Francisella tularensis--a model for studies of the immune response to intracellular bacteria in man. Immunology (1992) 1.18
Specific detection of Coxiella burnetii through partial amplification of 23S rDNA. Eur J Epidemiol (1997) 1.18
Stimulation of subpopulations of human lymphocytes by a vaccine strain of Francisella tularensis. Infect Immun (1978) 1.17
Phagocytosis and virulence of different strains of Porphyromonas gingivalis. Scand J Dent Res (1991) 1.14
Time of lymphocyte response after onset of tularemia and after tularemia vaccination. J Clin Microbiol (1979) 1.14
Persistence of cell-mediated immunity and decline of humoral immunity to the intracellular bacterium Francisella tularensis 25 years after natural infection. J Infect Dis (1994) 1.13
Cytokine expression in the liver of mice infected with a highly virulent strain of Francisella tularensis. FEMS Immunol Med Microbiol (1996) 1.13
Expansion of Vgamma9 Vdelta2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect Immun (1998) 1.12
Effect of amphotericin B and clotrimazole on lymphocyte stimulation. Antimicrob Agents Chemother (1974) 1.11
Monoclonal antibody HFD9 identifies a novel 28 kDa integral membrane protein on the cis-Golgi. J Cell Sci (1995) 1.10
Long-lasting cell-mediated immunity induced by a live Francisella tularensis vaccine. J Clin Microbiol (1985) 1.10
Ciprofloxacin for treatment of tularemia in children. Pediatr Infect Dis J (2000) 1.09
Geometric phases for mixed states in interferometry. Phys Rev Lett (2000) 1.09
Several membrane polypeptides of the live vaccine strain Francisella tularensis LVS stimulate T cells from naturally infected individuals. J Clin Microbiol (1990) 1.08
Influence of complement on the chemiluminescent response of human leukocytes to immune complex. Infect Immun (1980) 1.07
Infections with Francisella tularensis biovar palaearctica in hares (Lepus timidus, Lepus europaeus) from Sweden. J Wildl Dis (1988) 1.07
Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose. Vaccine (1999) 1.07